Latest Lead News

Richmond Vanadium Technology has paused parts of its feasibility study and approval processes in response to a prolonged downturn in vanadium prices, focusing instead on metallurgical innovation and cash conservation.

NuEnergy Gas Limited has completed drilling two wells at its Tanjung Enim PSC in Indonesia, advancing its early gas sales initiative targeting 1 million cubic feet per day. The company is finalizing a major gas sales agreement pending government approval.

Vault Minerals delivered a robust June quarter with 98,459 ounces of gold produced and a significant cash flow boost, while advancing major upgrades at its King of the Hills operation.

Canyon Resources has achieved critical milestones for its Minim Martap Bauxite Project, including port access approval and a substantial credit facility, setting the stage for production and first shipment in early 2026.

Platformo Ltd’s Biztrak business reported a robust 41% revenue increase in the June 2025 quarter, driven by software enhancements and training tied to Malaysia’s evolving e-invoicing regulations. The company also tightened cost controls, reducing net cash outflow while preparing for upcoming compliance deadlines.

Arovella Therapeutics reported a robust $20.9 million cash position as it prepares for its first-in-human trial of ALA-101 and expands its solid tumour pipeline through new licensing agreements and leadership appointments.

Bubs Australia has appointed Joe Coote as its new CEO, bringing extensive international FMCG and dairy leadership to spearhead its global growth ambitions in infant nutrition.

International Graphite Limited has partnered with Arctic Graphite AS to establish a new expandable graphite facility in Germany, aiming to bolster European supply with an initial 3,000 tonnes per year capacity. Backed by a potential $10 million funding commitment, this venture marks a strategic push into critical mineral processing amid rising demand.

Alterity Therapeutics has reported encouraging topline results from its open-label Phase 2 trial of ATH434 in advanced Multiple System Atrophy, showing slowed disease progression and biomarker stabilization.

PainChek Limited has raised A$7.5 million through a strongly supported placement to accelerate its US market entry following anticipated FDA clearance and expand its innovative AI pain assessment technology internationally.

Larvotto Resources has opened a $5 million Share Purchase Plan offering shares at a 13.5% discount to fund key development and exploration activities at its Hillgrove Project in NSW.

AML3D has appointed Arc Additive as its UK and European distribution partner, marking a strategic push into key manufacturing and defence markets across Europe. This move follows a successful capital raise and a contract with BAE Systems UK, underpinning AML3D’s growth ambitions.